ALEVEX
Live / Applied — Third extension granted (statement of use) (as of 10 Sept 2026)
What this means for you
Not registered yet, but its 30 Mar 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97865059
- Mark type
- Stylized text
- Filed
- 30 Mar 2023
- Published for opposition
- 28 Jan 2025
- Attorney of record
- Phillip Barengolts
Goods and services
- Class 005 — Pharmaceuticals: Transdermal patches featuring a nonsteroidal anti-inflammatory for use in treating pain, headaches, fever, inflammation, common cold symptoms, and joint stiffness; transdermal patches for use in the treatment of pain, headaches, fever, inflammation, common cold symptoms, and joint stiffness
Owner
- Bayer HealthCare LLC, Whippany, NJ, US
- Bayer HealthCare LLC, Whippany, NJ, US
Prosecution history
- 10 Sept 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Sept 2026 — SOU EXTENSION 3 GRANTED
- 09 Sept 2026 — SOU EXTENSION 3 FILED
- 09 Sept 2026 — SOU TEAS EXTENSION RECEIVED
- 13 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Mar 2026 — SOU EXTENSION 2 GRANTED
- 12 Mar 2026 — SOU EXTENSION 2 FILED
- 12 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 17 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Sept 2025 — SOU EXTENSION 1 GRANTED
- 16 Sept 2025 — SOU EXTENSION 1 FILED
- 16 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 25 Mar 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 28 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Jan 2025 — PUBLISHED FOR OPPOSITION